MedTrace Logo

Comparison of Two Salicylic Acid Formulations

NCT00848744 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2018-03-01

Study results available
· View outcomes & findings →

Summary

This study is a split face, paired-comparison, pilot study of at least 10 subjects to complete. Participants in this study will be patients seen at Children's Memorial Hospital, who are clinically diagnosed with mild to moderate acne vulgaris. Participants will be recruited from one of the clinics, as well as from previous Institutional Review Board (IRB) approved acne studies housed in the Department of Dermatology. All subjects accrued from previous studies have agreed to be contacted for further investigations. Subjects 13 to 35 years of age with mild to moderate acne vulgaris symmetrical in appearance on both sides of the face, and meeting inclusion criteria will be eligible to participate

Conditions

  • Acne Vulgaris

Interventions

DRUG

Formulation A

Formulation A will be applied to the randomly-assigned single (left or right) side of the face twice daily.

DRUG

Formulation B

Formulation B will be applied to the randomly-assigned single (left or right) side of the face twice daily.

Sponsors & Collaborators

Principal Investigators

  • Amy Paller, MD · Ann & Robert H Lurie Children's Hospital of Chicago

  • Dennis P West, PhD · Northwestern University Department of Dermatology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
13 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2008-08-31
Completion
2008-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00848744 on ClinicalTrials.gov